Most of the Miss Is Calendar and Comps. The $180M of Fresh Program Adjustments Is Not.
Key Takeaways
- A double miss on the headline lines. Sales of $18,021M came in 2.0% below the $18,380M consensus and EPS of $6.44 missed $6.79 by $0.35, with segment operating profit down 12.6% and margin down 149bps to 10.1%. The stock fell 4.6%.
- Most of that is explicable and management quantified it: the quarter ran twelve weeks against thirteen a year ago, and $240M of prior-year one-time profit events across three business areas do not repeat. Add back the current quarter's $180M of F-16 and C-130 adjustments and Q1 segment margin was 11.11%, almost exactly the 11.08% the rest of the year needs to hit the reaffirmed guide.
- What is not explicable is $180M of fresh unfavourable profit adjustments on F-16 ($125M, flight-test rework on a new configuration) and C-130 ($55M, supplier constraints), plus roughly $50M more at Sikorsky. After two quarters without a reach-forward loss, four programs took adjustments. This is the recurring fixed-price pattern, in different programs.
- The cash and capital-return picture deteriorated as we expected. Free cash flow was negative $291M against positive $955M, the buyback was zero against $750M a year ago, $1,000M of debt was retired, and backlog fell $7,195M to $186,427M, its first decline in our coverage. Management reaffirmed the full-year guide and attributes the cash timing to an ERP implementation resolving in Q2.
- Rating: Maintaining Hold. Our own $560 upgrade trigger was breached at the $529.79 close, but the quarter added risk on the side of the ledger the trigger did not contemplate. At 17.8x the reaffirmed midpoint we are close, and one clean cash quarter from moving.
Results vs. Consensus
| Metric | Actual | Consensus | Beat/Miss | Magnitude |
|---|---|---|---|---|
| Sales | $18,021M | $18,380M | Miss | -2.0% |
| EPS (GAAP diluted) | $6.44 | $6.79 | Miss | -5.2% |
| Segment operating profit | $1,823M | n/a | n/a | -12.6% YoY |
| Segment operating margin | 10.1% | n/a | n/a | -149bps YoY |
| Free cash flow | ($291M) | n/a | n/a | -$1,246M YoY |
| Backlog | $186,427M | n/a | n/a | -3.7% QoQ |
| FY2026 guidance | Unchanged | Above the guide | Reaffirmed | Street had drifted higher |
One framing correction is worth making up front, because it circulated widely on the day. Lockheed did not lower guidance. Every line of the 2026 outlook is identical to the January guide: sales $77,500M to $80,000M, segment operating profit $8,425M to $8,675M, EPS $29.35 to $30.25, free cash flow $6,500M to $6,800M. What happened is that consensus had drifted above the standing guide (roughly $29.94 on EPS and $79.1B on sales), so a reaffirmation read as a cut. That distinction matters for how the next three quarters get judged.
Year-over-Year Comparison
| Item ($M except per-share) | Q1 2026 (12 wks) | Q1 2025 (13 wks) | Change |
|---|---|---|---|
| Sales | 18,021 | 17,963 | +0.3% |
| Gross profit | 2,078 | 2,323 | -10.5% |
| Gross margin | 11.5% | 12.9% | -140bps |
| Business segment operating profit | 1,823 | 2,085 | -12.6% |
| Business segment operating margin | 10.1% | 11.6% | -149bps |
| Consolidated operating profit | 2,063 | 2,372 | -13.0% |
| Interest expense | (269) | (268) | +0.4% |
| Non-service FAS pension expense | (80) | (98) | +$18M |
| Earnings before income taxes | 1,774 | 2,036 | -12.9% |
| Effective tax rate | 16.1% | 15.9% | +20bps |
| Net earnings | 1,488 | 1,712 | -13.1% |
| Diluted EPS | $6.44 | $7.28 | -11.5% |
| Weighted average diluted shares (M) | 231.1 | 235.3 | -1.8% |
| Cash from operations | 220 | 1,409 | -84.4% |
| Capital expenditures | (511) | (454) | +12.6% |
| Free cash flow | (291) | 955 | -$1,246M |
| Share repurchases | 0 | (750) | -$750M |
Sequential Comparison
| Item ($M except per-share) | Q1 2026 (12 wks) | Q4 2025 (13 wks) | Change |
|---|---|---|---|
| Sales | 18,021 | 20,321 | -11.3% |
| Business segment operating profit | 1,823 | 2,058 | -11.4% |
| Business segment operating margin | 10.1% | 10.1% | -1bp |
| Net earnings | 1,488 | 1,344 | +10.7% |
| Diluted EPS | $6.44 | $5.80 | +11.0% |
| Free cash flow | (291) | 2,756 | -$3,047M |
| Total backlog | 186,427 | 193,622 | -$7,195M |
The sequential margin comparison is the most useful single line in either table. Segment margin was 10.116% this quarter against 10.128% in Q4, essentially unchanged, in a quarter with 7.7% fewer operating days and $180M of unfavourable adjustments. That is a business holding its ground, not one deteriorating.
- The twelve-week quarter. Q1 2026 closed March 29 and contained twelve weeks against thirteen in Q1 2025, roughly 7.7% fewer operating days. Management sized the revenue effect at "a few hundreds of millions of dollars," recovered in a fourteen-week Q4. Flat reported sales on 7.7% fewer weeks implies a materially higher weekly run rate.
- Absent prior-year one-time benefits. Management quantified the non-recurring profit events across three business areas at approximately $190M of sales and $240M of profit. The release names the three components approximately: a classified Aeronautics program completion benefit (~$80M), a Space commercial civil at-completion adjustment (~$125M), and an RMS intellectual property licence cost recovery (~$50M), which sum to slightly more than management's rounded aggregate. Against a $262M segment profit decline, those three explain $240M of it. Excluding them, segment profit fell $22M and margin fell 26bps rather than 149bps.
- Fresh unfavourable adjustments, $180M. F-16 took $125M on production performance and development delays tied to a new configuration for the Taiwan and Morocco run, and C-130 took $55M on supply chain integration and delivery delays. Roughly $50M more came at Sikorsky on CH-53K and Seahawk. This is the part that is neither calendar nor comparison, and it is the part that matters.
Assessment: revenue. Flat reported sales in a quarter with 7.7% fewer operating days is a better outcome than the headline conveys, and the composition was directionally right: Missiles and Fire Control up 8.2% and Space up 7.0%, against Aeronautics down 1.5% on classified program lifecycle and RMS down 7.8% on radar volume and Sikorsky material timing. The segments that are supposed to be growing grew, and the segments that shrank did so for reasons management could name and date. Adjusting for the $190M of prior-year one-time sales, underlying growth was 1.4%, which is still short of the 4.9% the full year requires and is the reason we treat the reaffirmed guide as demanding rather than conservative.
Assessment: margins. Here is the calculation that decides how to read this quarter. Reported segment margin was 10.12%. Add back the $180M of current-quarter unfavourable adjustments and it is 11.11%. The reaffirmed full-year guide requires 11.08% across the remaining forty weeks. In other words, a Q1 in which nothing went wrong on F-16 and C-130 would have run at almost exactly the rate the rest of the year needs, and adding back the Sikorsky items too would have cleared it. That is genuinely reassuring about the underlying earning power and genuinely unreassuring about the reliability of getting it, because adding back unfavourable adjustments every quarter is precisely the analytical move that lets a recurring problem look non-recurring. Lockheed has now taken unfavourable program adjustments in each of the three quarters we have covered.
Assessment: EPS. EPS of $6.44 fell 11.5% while net earnings fell 13.1%, the gap being the 1.8% lower share count carried over from prior repurchases. That tailwind is now ending: the company bought back nothing in the quarter against $750M a year ago, and retired $1,000M of long-term debt instead. Below the line, the picture actually improved, with pension expense $18M lower and interest flat. The $44M pre-tax deferred compensation mark-to-market loss ($0.14 per share) is noise. This quarter's EPS decline is an operating result, not a below-the-line one, which is a reversal of the pattern that defined the prior three quarters.
Segment Performance
| Segment | Q1 2026 Sales | YoY | Q1 2026 Op Profit | YoY | Q1 2026 Margin | Margin YoY |
|---|---|---|---|---|---|---|
| Aeronautics | $6,953M | -1.5% | $619M | -14.0% | 8.9% | -130bps |
| Missiles and Fire Control | $3,649M | +8.2% | $500M | +7.5% | 13.7% | -8bps |
| Rotary and Mission Systems | $3,991M | -7.8% | $423M | -18.8% | 10.6% | -144bps |
| Space | $3,428M | +7.0% | $281M | -25.9% | 8.2% | -363bps |
| Total | $18,021M | +0.3% | $1,823M | -12.6% | 10.1% | -149bps |
Backlog by Segment
Backlog declined for the first time in our coverage, and it declined in all four segments.
| Segment | March 29, 2026 | December 31, 2025 | Change |
|---|---|---|---|
| Aeronautics | $55,032M | $59,435M | ($4,403M) |
| Missiles and Fire Control | $46,565M | $46,650M | ($85M) |
| Rotary and Mission Systems | $45,840M | $47,715M | ($1,875M) |
| Space | $38,990M | $39,822M | ($832M) |
| Total | $186,427M | $193,622M | ($7,195M) |
Assessment. A 3.7% sequential decline is not alarming on its own: Q1 is seasonally a light bookings quarter and Q4 2025 had just absorbed the $11.9B F-35 Lot 18/19 definitization, so the comparison is against an unusually full book. Backlog still stands at 2.37x guided 2026 sales. The line that deserves attention is Missiles and Fire Control at essentially flat, down $85M, against $2.2B of PAC-3 awards booked inside the quarter and a further $4.8B signed in April. That combination says MFC is now converting backlog to revenue about as fast as it is adding it, which is what a production ramp looks like, and it means the segment's future growth depends on definitizing the multiyear agreements rather than on the book it already holds.
Missiles and Fire Control — the one segment that did what it promised
MFC grew sales 8.2% to $3,649M on roughly $190M of PAC-3 production ramp and roughly $75M of tactical and strike missiles (JASSM, LRASM, PrSM). Operating profit rose 7.5% to $500M and margin was 13.70% against 13.79%, a decline of 8 basis points.
That 8bps is the single most important number in the quarter for the long-term thesis. In January management committed that ramp dilution would be "no more than 20 to 30 basis points at max." One quarter into the ramp, dilution is 8bps.
Order activity was heavy: roughly $7B of PAC-3 awards comprising a $2.2B contract in the quarter and a $4.8B fully funded undefinitized contract signed in April. Management now targets tripling PAC-3 and quadrupling THAAD and PrSM production rates.
"So the goal is to sort of have a ratable increase from our current levels of production, which is last year 650 Patriot missiles per year up to 2,000. And that's going to take 3 to 4 years depending on supply chain and other considerations, but we really do think we can get it done in 3 to 4 years."
— James Taiclet, Chairman, President and Chief Executive Officer
Assessment: MFC delivered on both halves of what it promised in January, growth and margin discipline, and it did so while absorbing the front-end costs of the largest capacity expansion in the segment's history. The three-to-four-year framing for reaching 2,000 units is longer than the January messaging implied, which is a mild negative for the modelling but a positive for credibility. This pillar of the thesis is now the strongest it has been.
Aeronautics — the problem segment this quarter
Aeronautics sales fell 1.5% to $6,953M, with F-35 sustainment volume up roughly $325M offset by classified program lifecycle down roughly $325M and F-16 down roughly $145M. Operating profit fell 14.0% to $619M and margin fell 130bps to 8.9%, second-lowest in the portfolio behind Space. The composition of the profit decline is instructive: F-16 unfavourable adjustments of $125M and C-130 of $55M, plus the absence of an $80M prior-year classified benefit, partly offset by $130M of favourable F-35 adjustments.
Deliveries reflected the disruption: 32 F-35s against 47, and zero F-16s against four. Management explained the F-16 issue as configuration-specific rather than systemic.
"So we ran into some issues during the flight test causing some rework, which delayed deliveries. So the combined cost of the rework and schedule extension ran through our program estimate."
— James Taiclet, Chairman, President and Chief Executive Officer
The offsetting news was commercial rather than operational: a $1.5B contract with the Peruvian Air Force for 12 Block 70 F-16s with an option for a further 12, described as the first F-16 direct commercial sale contract in decades.
Assessment: The F-35 line is performing well, with $130M of favourable adjustments and sustainment growth that management called accretive to segment margin. The problem is everything around it. F-16 and C-130 together cost $180M in a segment that earned $619M, and both are mature production programs where this kind of surprise should not happen. The Peru win is genuinely valuable for the F-16 franchise's future, but it does not offset the message that Aeronautics' execution outside the F-35 remains unreliable.
Space — a 363bps margin decline that is almost entirely a comparison
Space grew sales 7.0% to $3,428M on roughly $245M of higher strategic and missile defense volume (Fleet Ballistic Missile, Next Generation Interceptor). Operating profit fell 25.9% to $281M and margin fell 363bps to 8.2%, driven by roughly $125M of lower profit booking rate adjustments, essentially all of it the absence of a prior-year favourable at-completion adjustment on commercial civil space programs.
The quarter's marquee event was operational rather than financial: the Orion spacecraft carried the Artemis II crew around the moon and returned safely, the first crewed flight beyond low earth orbit since 1972. Space also booked an $890M Fleet Ballistic Missile contract.
Assessment: Add back the $125M prior-year benefit and Space margin would have been roughly 11.8%, in line with the prior year. This is a comparison artifact, not a deterioration, and the underlying growth engine (strategic and missile defense) is the fastest in the segment's portfolio. Space remains guided to approximately 5% growth at a margin slightly above 10% for the year, and nothing in Q1 contradicts that. Orion's success has no near-term financial consequence but materially strengthens the franchise position on Artemis III through V.
Rotary and Mission Systems — still the weakest execution in the portfolio
RMS sales fell 7.8% to $3,991M on roughly $170M of lower radar and sensors volume and roughly $110M at Sikorsky (CH-53K, Seahawk, Black Hawk) from both volume and unfavourable adjustments. Operating profit fell 18.8% to $423M and margin fell 144bps to 10.6%, with roughly $50M of unfavourable CH-53K and Seahawk adjustments and the absence of a roughly $50M prior-year intellectual property licence recovery. The segment delivered the first UH-60MX Black Hawk to the U.S. Army, carrying an integrated autonomy suite enabling optionally piloted flight.
Assessment: This is the fourth consecutive quarter in which Sikorsky has been a source of negative news: helicopter program charges in Q2 2025, a $500M in-year revenue cut in Q3, unfavourable Black Hawk adjustments in Q4, and now CH-53K and Seahawk adjustments plus a volume decline. Management attributes the volume to material receipt timing and expects it to reverse. We have heard a version of that each quarter. RMS is guided to low-single-digit growth at a 10.5% margin for the year, and Q1 leaves it needing a visible acceleration to get there.
Key Topics & Management Commentary
Overall Management Tone: Confident and unusually specific, with none of the defensiveness a double miss might have produced. Management led with operational proof points rather than financial ones, quantified the comparison effects rather than gesturing at them, and volunteered contract-level detail on the munitions frameworks that had not previously been public. The weakest passage was on free cash flow, where the explanation was adequate but the reliance on a second-half weighting is the same assurance the market has been asked to accept before.
1. The reaffirmed guide and the 96bps it requires
Management reaffirmed every line of the January outlook and stated plainly where the recovery comes from.
"It is also important to note that we expect margins to improve over the course of the year, with gains anticipated in the second half of 2026 as production milestones are achieved and risks are retired."
— Evan Scott, Chief Financial Officer
The arithmetic behind that is demanding but not implausible. Q1 delivered $18,021M of sales, 22.9% of the guided midpoint, against twelve weeks that represent 23.1% of the year, so revenue is essentially on pace. Segment profit of $1,823M is 21.3% of the midpoint, leaving $6,727M to be earned on $60,729M of remaining sales, an 11.08% margin against the 10.12% just delivered.
Assessment: A 96bps margin recovery over three quarters is a real ask, but it is the same recovery implied by adding back this quarter's $180M of unfavourable adjustments. If Q2 through Q4 simply avoid new program surprises, the guide is met. The guide is therefore best read as a statement that management believes the F-16, C-130 and Sikorsky issues are contained. That is the whole bet.
2. Free cash flow: negative, and the explanation
Free cash flow of negative $291M compares to positive $955M a year ago, with cash from operations collapsing 84.4% to $220M. Management attributed it to working capital timing.
"The negative cash was largely driven by working capital timing, including impacts from the implementation of a new ERP system in one of our business areas. The impact of this system upgrade was anticipated and we expect that the effect will be resolved by the second quarter."
— Evan Scott, Chief Financial Officer
Management added a specific offsetting positive: favourable IRS guidance on the corporate alternative minimum tax issued during the quarter, which it said strengthens confidence in reaching the upper end of the $6,500M to $6,800M range. Reaching even the midpoint requires $6,941M over the remaining three quarters.
Assessment: The ERP explanation is credible, specific, and falsifiable by Q2, which is more than most working-capital explanations offer. It is also connected to something we already know is true: the company surged collections into Q4 2025 to fund the $860M pension pre-payment, which necessarily pulled cash out of Q1. What we cannot verify is the magnitude. A company that needs $6,941M in three quarters after burning $291M in one has left itself no room for a second timing surprise.
3. The buyback went to zero
Lockheed repurchased no shares in Q1 2026 against $750M in Q1 2025, paid $816M of dividends, and retired $1,000M of long-term debt. This is the resolution of the question management declined to answer twice in January, and it resolves in the direction we assumed.
Assessment: Prioritising debt reduction over repurchases while capex rises 61% is defensible capital allocation and probably the right call at 18x earnings with a munitions ramp to fund. But it removes the mechanism that has supplied most of Lockheed's EPS growth. The share count fell 1.8% year over year on the strength of prior repurchases; without new buying, that tailwind decays to zero over the next several quarters. Any 2027 EPS model that assumes a continued 2% share shrink now needs justifying.
4. The munitions frameworks: clawback, escalators, and advance payments
The most substantive disclosure of the call was the contractual architecture behind the seven-year munitions agreements, described in more detail than at any prior point. Three provisions matter.
First, a clawback mechanism protecting against a change in government procurement strategy.
"There's clawback arrangements with the government then the agreements and will be in the contracts to make sure that we're whole. And if there's a change in government policy or a reduction in the production rate that they request down the road, we will not be harmed by that."
— James Taiclet, Chairman, President and Chief Executive Officer
Second, inflation protection on a seven-year fixed-price commitment.
"So fixed price to start with inflation-based escalator for the 7-year period that's based on an index for the industry."
— James Taiclet, Chairman, President and Chief Executive Officer
Third, and most consequentially for the cash bridge, government advance payments.
"And so we were going to get and will get under these agreements, advanced payments from the government to make this program for -- and all of these long-term agreements, cash flow neutral for the OEM and for Lockheed Martin in our case."
— James Taiclet, Chairman, President and Chief Executive Officer
Management also confirmed that major suppliers (L3Harris on solid rocket motors, Boeing on seekers) are funding their own non-recurring engineering, so Lockheed's investment is directed at small and medium suppliers, supported by Office of Strategic Capital equity and debt instruments.
Assessment: Taken together these three provisions transform the risk profile of the capex commitment we flagged as a new bear point in January. A fixed-price seven-year agreement with an industry-indexed escalator, a clawback for rate reductions, and advance payments that make the arrangement cash-flow neutral is close to the best contract structure a prime could ask for. The caveat is unchanged: these are frameworks in definitization, and the provisions are described rather than filed. But if they land as described, the capital-intensity bear point weakens considerably.
5. Both classified programs stayed clean, and the CEO's strongest statement yet
Neither the classified Aeronautics program nor the classified MFC program took a charge in the quarter. On the Aeronautics program, the CEO went further than at any prior point in our coverage.
"So I would say that from my perspective and what I can share on this call, I feel better about that program than I have probably since I got here 6 years ago."
— James Taiclet, Chairman, President and Chief Executive Officer
He paired it with a hedge that is by now standard.
"We do think we have a path through the flight test and other parts of this program. that have sufficient coverage, I'll call it, in our financials right now to hopefully not experience any additional write-downs of the program. But it is complex."
— James Taiclet, Chairman, President and Chief Executive Officer
On the classified MFC program, management noted the last charge was taken in Q4 2024 with no change in estimate since. Cash burn across the classified portfolio was guided to $500M to $700M annually for 2026 and 2027, with a sizable drawdown thereafter.
Assessment: Three consecutive clean quarters on the program that cost $950M in Q2 2025 is a genuine achievement and the strongest evidence yet that the reset held. The irony of this quarter is that the classified programs behaved and the unclassified, mature, supposedly low-risk ones (F-16, C-130, Seahawk) did not. That is a useful corrective to how the risk has been framed: Lockheed's fixed-price exposure is not concentrated in exotic development work, it is distributed across a portfolio of production programs, any of which can surprise.
6. Capital intensity, with a cash offset we did not have in January
Capital expenditures of $511M were up 12.6%, and combined capex and research and development of $969M was up approximately 15% year over year, consistent with the guided full-year step-up. What is new is disclosure that roughly half the increase carries customer cash protection.
"So if you think about the $1 billion increase year-over-year on CapEx we've had. I think about half of that tied to these agreements that have this kind of cash flow protection."
— Evan Scott, Chief Financial Officer
Construction or modernisation is underway at more than 20 facilities across several states.
Assessment: This materially changes the economics of the capex we criticised in January. If roughly $500M of the $1,000M increase is offset by customer advance payments, the true shareholder-funded increment is half what the capex line suggests. It also explains how cash from operations can be guided up 8.7% on 4.9% sales growth. We continue to think management should have disclosed this alongside the original capex guide rather than three months later.
7. Supply chain pinch points for the ramp
Management identified the two binding constraints on tripling PAC-3 output as solid rocket motors and seekers, and described the resolution of each: L3Harris spinning out its solid rocket motor business with government financing support, Northrop Grumman potentially expanding into Patriot, a General Dynamics joint venture, and Boeing publicly committing to invest in seeker capacity. The seven-year agreement horizon is what makes second and third sourcing economically rational, because the non-recurring cost of qualifying an additional supplier can be amortised.
Assessment: The supply chain answer has improved materially over three quarters, from a CEO "much more confident today than I was a year or so ago" in October to named companies with public commitments and financing mechanisms in April. Three solid rocket motor pathways against one bottleneck two years ago is a structural change to the industry, not just to Lockheed. The three-to-four-year timeline to full rate is the honest constraint, and it means the revenue from this ramp is a 2028 and 2029 event.
8. International demand and the Peru breakthrough
The $1.5B Peruvian Air Force contract for 12 Block 70 F-16s, with an option for a second squadron, was signed as the first F-16 direct commercial sale in decades. Management framed it as broadening the footprint in Latin America and as a collaborative effort with the U.S. government. Other international activity included a $700M F-35 long-lead award for international partners and a $462M Royal Canadian Air Force C-130J support contract.
Assessment: The direct commercial sale structure is the interesting part, not the dollar value. Foreign military sales run through the U.S. government and carry its timelines and margins; a direct commercial sale is faster and typically better priced for the contractor. If this becomes a repeatable channel it improves both the growth rate and the margin mix of a franchise that has otherwise been in slow decline. It is also an odd counterpoint to a quarter in which F-16 execution cost $125M.
9. Operational proof points as a demand signal
The CEO devoted much of the prepared remarks to platform performance in recent operations: F-22 and F-35 establishing air superiority, PAC-3 and THAAD interceptors providing layered air and missile defense, and Black Hawk and C-130 supporting combat search and rescue. He connected it directly to procurement, noting that PrSM production was slated to quadruple in the weeks following its first operational use.
Assessment: This is the most reliable leading indicator in the defense sector and it is the reason the munitions ramp has the political durability it does. Weapons that are consumed in operations get replenished, and weapons that perform visibly get ordered by allies. It does not appear in backlog until it is contracted, which is exactly why the framework agreements matter: they are the mechanism converting demonstrated demand into committed production.
10. The venture fund doubles
Lockheed expanded its venture fund capacity to $1B, more than double its prior size, having backed more than 120 companies with 25 added in the past two years and many now serving as suppliers. It also announced a strategic investment in a counter-UAS technology company to be integrated into Lockheed's own counter-drone ecosystem.
Assessment: A $1B venture commitment is small relative to a $2.65B capex program and is the cheapest way to buy optionality on technologies the company would otherwise have to develop or acquire at scale. Counter-UAS specifically is a real and growing requirement where Lockheed has no dominant position. This is sensible capital allocation at a size that does not move the thesis.
Guidance & Outlook
| Metric | January 2026 guide | April 2026 guide | Status |
|---|---|---|---|
| Net sales | $77,500M – $80,000M | $77,500M – $80,000M | Reaffirmed |
| Business segment operating profit | $8,425M – $8,675M | $8,425M – $8,675M | Reaffirmed |
| Total FAS/CAS pension adjustment | ~$1,365M | ~$1,365M | Reaffirmed |
| Diluted EPS | $29.35 – $30.25 | $29.35 – $30.25 | Reaffirmed |
| Cash from operations | $9,150M – $9,450M | $9,150M – $9,450M | Reaffirmed |
| Capital expenditures | $2,500M – $2,800M | $2,500M – $2,800M | Reaffirmed |
| Free cash flow | $6,500M – $6,800M | $6,500M – $6,800M | Reaffirmed |
What the reaffirmation implies for the rest of the year:
| Metric | Q1 2026 actual | Required, remaining 40 weeks | Comment |
|---|---|---|---|
| Sales | $18,021M (22.9% of FY midpoint) | $60,729M | On pace against 23.1% of FY weeks |
| Segment operating profit | $1,823M (21.3% of FY midpoint) | $6,727M | Behind pace |
| Segment operating margin | 10.12% | 11.08% | Requires +96bps |
| Diluted EPS | $6.44 (21.6% of FY midpoint) | $23.36 | Behind pace |
| Free cash flow | ($291M) | $6,941M | Entire year still to earn |
Street at: Consensus entering the print sat at roughly $29.94 on 2026 EPS and $79.1B on sales, above the company's standing guide midpoints of $29.80 and $78,750M. The reaffirmation therefore pulls the Street down toward the guide rather than the company cutting toward the Street.
Guidance style: Consistent with the pattern across our coverage. Lockheed beat every 2025 guided line and has now declined to trim 2026 after a quarter that missed consensus on both headline lines. That is either confidence or stubbornness, and the distinction will be visible in July. The one place management leaned forward was cash, where it flagged the corporate alternative minimum tax guidance as supporting the upper end of the free cash flow range, an unusual specificity after a negative quarter.
Analyst Q&A Highlights
What drove the adverse profit adjustments at Aeronautics and Sikorsky
An early question went after the profit adjustments directly, acknowledging the difficult comparison but asking what actually happened on F-16 and at Sikorsky, and what offset them on F-35. The answer was specific and program-level: a new F-16 configuration on the Taiwan and Morocco run hit flight-test problems requiring rework, with the combined cost of rework and schedule extension flowing through the program estimate.
Q: "I thought you could give some additional color on Aeronautics and RMS results. Some of this was a difficult comp, but I wanted to know if you could maybe give some more color on your opening remarks and discuss what drove the adverse profit adjustments on the F-16 at Sikorsky and also on the F-35 that offset."
— Richard Safran, Seaport Research Partners
A: "Unfortunately, we're back on track with a successful flight test and plan to deliver -- begin deliveries of the first aircraft as soon as this week."
— James Taiclet, Chairman, President and Chief Executive Officer
Assessment: The most useful disclosure in the whole call came in this answer, where management quantified the prior-year one-time events across three business areas at approximately $190M of sales and $240M of profit, which reconciles $240M of the $262M segment profit decline. That is the kind of specificity that lets an analyst separate signal from comparison. The F-16 explanation is configuration-specific and time-bounded, and deliveries resuming within days is checkable. RMS got a thinner answer, described as material timing and a quarterly anomaly, which is the fourth consecutive quarter Sikorsky's problems have been characterised as timing.
The downside if the committed production rates are not reached
The sharpest question of the call asked what the company is actually signing up for in the multiyear agreements and what happens financially if the rates never materialise. The answer produced the most detailed public description yet of the contract architecture, covering clawback provisions, supplier-funded non-recurring engineering, an inflation-indexed escalator, and government advance payments designed to make the arrangement cash-flow neutral.
Q: "But can you also help us think a little bit about the risk side? Are you signing up and committing to reach these significantly higher production rates in the out years? And how do we think about what the financial downside could be for the company if these rates aren't reached?"
— Seth Seifman, JPMorgan
A: "So I think this is a very well risk-managed arrangement."
— James Taiclet, Chairman, President and Chief Executive Officer
Assessment: The four mechanisms described (clawback, supplier-funded NRE, inflation escalator, advance payments) collectively address every objection we raised to the capex program in January. If they survive definitization as described, the munitions investment carries materially less downside than a conventional capacity build. The unresolved issue is that we are relying on a verbal description of contracts still being definitized, and the clawback in particular has never been tested. We give it substantial but not full credit.
Risk trend on the classified Aeronautics program
A recurring line of questioning across our coverage returned to the program that produced the $950M charge in Q2 2025. Management confirmed a third consecutive clean quarter, described increased executive oversight, and offered its most positive characterisation yet while still declining to declare the risk retired.
Q: "Jim, can you share an update on the classified program in Aeronautics, including how risk is trending on the program? And then are you seeing any willingness from the government to provide additional funding to support your efforts to keep that program on track?"
— Scott Deuschle, Deutsche Bank
A: "We have increased the scrutiny on that program. And actually, again, the higher levels of operating executives in this company is now overseeing that program."
— James Taiclet, Chairman, President and Chief Executive Officer
Assessment: Three clean quarters plus a statement that the CEO feels better about the program than at any point in six years is about as much comfort as this disclosure regime permits. The second half of the question, about whether the government would provide additional funding, drew an answer about ongoing discussions on contract structure rather than a commitment, which is worth noting: a renegotiated structure would be the clearest possible signal that the risk is genuinely contained.
Free cash flow cadence and what gets it to the full-year guide
The most consequential financial question asked whether the Q1 cash use was F-35-related and how the remaining three quarters bridge to the guide. Management pointed to the ERP transition, noted that the Q4 2025 collections surge that funded the pension pre-payment necessarily pulled cash forward, and leaned on the historical second-half weighting plus favourable tax guidance.
Q: "And then second, as you think about the full year guide, how should we think about the cadence here in the second quarter and in the second half of the year to hit the full year guide on the free cash?"
— Ken Herbert, RBC Capital Markets
A: "I think as you look throughout the year and the pace of our deliveries and program milestones, we're going to continue to see cash increase throughout the year, it's going to be back-end loaded, not unlike previous years, but I think we've demonstrated our ability to close the year strong and hit our cash flow guide."
— Evan Scott, Chief Financial Officer
Assessment: The appeal to track record is legitimate; Lockheed beat its 2025 cash guide by $308M while making an $860M discretionary pension contribution. But the required $6,941M over three quarters is a larger ask than any recent year, and the answer contained no quantified bridge, only a shape. This is the single line item on which the year will be judged, and Q2 is the first checkpoint because the ERP effect is supposed to clear by then.
Pinch points in ramping missile capacity
A question on how quickly missile capacity can physically be raised drew a detailed supply chain answer naming the two binding constraints and the specific commitments addressing each, along with a longer timeline than prior messaging had implied.
Q: "Was wondering if you could comment on the pinch points in ramping MFC capacity. I know you guys have the JV you're building with GD on solid rocket motors and just wanted to see like how quickly can missile capacity actually be raised?"
— Gautam Khanna, TD Cowen
A: "The second area is the seeker for the Patriot. And Boeing is similarly made a public commitment and one to the government that says, hey, we're going to invest in that seeker business."
— James Taiclet, Chairman, President and Chief Executive Officer
Assessment: Three solid rocket motor pathways and a committed seeker supplier is a substantially better answer than the same question drew in October. The three-to-four-year timeline to 2,000 units is the number to carry: it means peak munitions revenue is a 2029 to 2030 event, not a 2027 one, and it should temper how much of the ramp gets capitalised into current estimates.
The work-week comparison and the cash protection on capex
A clarifying question sought the growth rate adjusted for the shortened quarter and asked what working capital assumptions underpin the cash guide against the higher capital spending. Management sized the calendar effect, put the classified program cash burn at $500M to $700M annually through 2027, and disclosed that roughly half the capex increase carries customer cash protection.
Q: "Clarification question would be around what your growth rate would have been ex the work week comparison if you had the same number of work weeks this quarter."
— David Strauss, Wells Fargo
A: "So I think of the shorter week or shorter time period of this quarter being kind of in the few hundreds of millions of dollars of revenue thereabouts. So we'll get that extra time back in 4Q, just so we're all tracking to the same calendar there."
— Evan Scott, Chief Financial Officer
Assessment: "A few hundreds of millions" is looser than the question deserved. At $18,021M over twelve weeks, one additional week would be roughly $1.5B on a straight-line basis, so management is implicitly saying most of a week's revenue would have landed anyway. That is plausible for a business with milestone-based recognition but it is not the same answer as the arithmetic, and the difference between "a few hundred million" and "$1.5B" is the difference between flat and up 8%. The capex cash-protection disclosure, arriving here rather than in January, was the more valuable half of the answer.
Whether the classified MFC missile program could get an acceleration agreement
Drawing an analogy to a competitor's restructured bomber production agreement, an analyst asked whether the classified MFC missile program could be renegotiated for accelerated production and better economics. Management confirmed heightened customer demand, a third clean quarter on that program within our coverage, and openness to a similar contracting approach.
Q: "Given the strong demand for missiles and munitions, is there an opportunity to reach an agreement with the customer to accelerate production of the classified missile program at MFC that could yield some better economics for Lockheed."
— Scott Mikus, Melius Research
A: "It's an MFC volume missile program, which could be subject to a similar contracting approach if the government decides to do that."
— James Taiclet, Chairman, President and Chief Executive Officer
Assessment: An unpriced call option worth watching. The program took its last charge in Q4 2024 with no change in estimate since, so the baseline is stable, and applying the PAC-3 framework structure (escalators, advance payments, clawback) to a program that has already produced a $1.4B loss would be a meaningful de-risking. Nothing here is contracted and we assign it no value, but it is a plausible positive catalyst.
What They're NOT Saying
- A quantified free cash flow bridge. The company needs $6,941M over three quarters after burning $291M. Management offered a shape (back-end loaded, ERP resolving in Q2, favourable tax guidance) but no quarterly path and no sizing of the ERP effect. For the metric that carries the most doubt, that is the thinnest disclosure in the release.
- Whether the buyback resumes, and when. Zero repurchases in the quarter answered January's unanswered question by action rather than by statement. Management did not address the repurchase authorisation, the pace, or the conditions under which it restarts.
- The real work-week adjusted growth rate. Asked directly, management gave "a few hundreds of millions of dollars thereabouts" against a week that is worth roughly $1.5B on a straight-line basis. The adjusted growth rate is the single number that determines whether the top line is on track, and it was not given.
- Whether the F-16 and C-130 adjustments are complete. Both were described as resolved, with F-16 deliveries resuming within days and four C-130s delivered. Neither answer stated whether the estimates at completion now carry sufficient coverage for the remaining work, which is the question that determines whether these repeat in Q2.
- What is actually happening at Sikorsky. Four consecutive quarters of negative news across four different programs, each explained as timing or a discrete issue. No structural diagnosis has been offered and no segment-level remediation plan disclosed, despite RMS carrying $45,840M of backlog.
- The total cost of the munitions capacity program. More than 20 facilities across several states are now under construction or modernisation, and the three-year total remains undisclosed a second consecutive quarter. Only "the initial portion" sits in the 2026 guide.
- Whether the clawback and escalator provisions are in signed contracts or still in frameworks. The description was detailed and the language shifted between what "will be in the contracts" and what has been agreed. Since these provisions carry most of the risk mitigation on a multibillion-dollar capital commitment, the distinction matters.
Market Reaction
- Pre-print setup: LMT closed at $555.43 on April 22, down 9.0% over the trailing thirty days and 17.9% below the $676.70 52-week closing high. The stock was nonetheless still up 14.8% year to date against the S&P 500's 4.3%, and up 19.8% over the trailing twelve months.
- Reaction session: The stock gapped down 3.9% to open at $533.91, traded a $522.26 to $538.81 range, and closed at $529.79, down 4.6% or $25.64.
- Volume: 3.2M shares against a 1.4M thirty-day average, 2.3x normal.
- Benchmark: The S&P 500 fell 0.4% on the session, so roughly four points of the decline were stock-specific.
The reaction was orderly and contained: the stock gapped down 3.9%, made its low at $522.26, recovered only as far as $538.81, and closed near the middle of a narrow range. That is a repricing rather than a panic, and the two things being repriced are visible in the release. The first is the EPS miss, which is largely comparison-driven. The second is the cash line, which is not. A company that guides $6,650M of free cash flow and delivers negative $291M in the first quarter has to carry the burden of proof for the remaining three, and the market charged it accordingly.
The setup matters for how much of this is fundamental. LMT entered the print having already surrendered 17.9% from its high, in a drawdown that began well before the quarter. The January print took the stock to $622.51 on a guide the market subsequently decided it had overpaid for, and the trailing thirty-day decline of 9.0% says positioning had already been unwinding. Against that, a 4.6% reaction to a genuine double miss is measured. The name has now given back most of its post-January re-rating while the guide behind it is unchanged, which is the first time in our coverage that the price has moved further than the fundamentals.
Street Perspective
Debate: Is the reaffirmed guide credible after a first quarter this weak?
Bull view: The bull case being made on the Street is that Q1 was mechanically disadvantaged and management has quantified exactly how: twelve weeks instead of thirteen, and $240M of prior-year one-time profits across three segments. Normalise both, plus the $180M of discrete adjustments, and Q1 ran at an 11.11% segment margin, essentially identical to the 11.08% the rest of the year requires. Revenue is on pace at 22.9% of the guide against 23.1% of the year's weeks.
Bear view: The bear camp contends that "normalise the bad things and the quarter was fine" is the argument made about every disappointing quarter, and that Lockheed has now taken unfavourable program adjustments in each of the three quarters covered. A guide requiring a 96bps margin recovery and $6,941M of free cash flow in three quarters, held unchanged after a double miss, is a company defending a number rather than forecasting one.
Our take: Both are right about different things and the resolution is empirical rather than rhetorical. The bulls have the better arithmetic: the normalisation is management-quantified, checkable, and lands precisely on the required run rate. The bears have the better prior: a portfolio that produces $180M of surprises in a quarter will produce more. Our position is that the guide is achievable and not yet demonstrated, which is why the rating does not move on this print.
Debate: Do the framework agreements de-risk the capital program?
Bull view: The bull case is that this quarter disclosed the best contract architecture a prime has obtained in modern memory: seven-year fixed price with an industry-indexed inflation escalator, clawback provisions making the company whole if rates are cut, major suppliers funding their own non-recurring engineering, and government advance payments making the arrangement cash-flow neutral. Roughly half the $1B capex increase carries customer cash protection. The capital-intensity objection largely dissolves.
Bear view: The bear camp contends that none of this is in a definitized contract yet, that the language shifted between what has been agreed and what "will be in the contracts," and that a clawback provision has never been tested against a Congress that changes its mind. Meanwhile the observable facts are that free cash flow is negative, the buyback is zero, debt is being retired instead of shares, and the total cost of the capacity program remains undisclosed after two quarters of asking.
Our take: The bulls have the stronger case here and it is the most important upgrade to our view this quarter. If the four provisions land as described, the capital-intensity bear point we opened in January is substantially weaker than we thought, and the cash-flow-neutral structure explains how operating cash can grow 8.7% on 4.9% revenue growth. We are moving that bear point from emerging back toward contained, while holding the reservation that we are pricing a description rather than a filing.
Debate: Is 17.8x the right entry point?
Bull view: At $529.79 the stock trades at 17.8x a reaffirmed guide midpoint, down from 20.9x in January, with a 5.4% free cash flow yield and a 2.6% dividend. It is 21.7% below its high on a guide that has not changed, three clean quarters into the classified program reset, with MFC delivering 8bps of dilution against a 30bps commitment. This is the de-rating long-term holders were waiting for.
Bear view: The bear camp contends the multiple is only cheap against a number that has not been earned. On a trailing basis the company just produced $6.44 of EPS and negative free cash flow, the share count tailwind is ending, backlog declined, and four programs took adjustments. A defense prime with unreliable quarterly execution and no buyback deserves a lower multiple than one with both.
Our take: We reduce our multiple band to 18x to 20x from 20x to 22x, reflecting the re-emergence of program adjustments, the first backlog decline, negative free cash flow and the suspended buyback. Applied to the $29.80 guided midpoint that gives a fair value range of $536 to $596, midpoint $566, implying roughly 7% upside plus a 2.6% dividend. That is a better risk-reward than we have had in this name and it is still not enough to move the rating, because the entire case rests on three quarters that have to go right in a row.
Model Update Needed
| Item | Our prior estimate | Our new estimate | Reason |
|---|---|---|---|
| FY2026 sales | $78,750M | $78,750M | Unchanged. Q1 tracked at 22.9% of the midpoint against 23.1% of the year's weeks; the guide was reaffirmed. |
| FY2026 segment operating margin | 10.9% | 10.7% | Trimmed 20bps. Q1's 10.12% leaves a 96bps recovery required, and we assume one further quarter of modest adjustment drag rather than a clean run. |
| FY2026 diluted EPS | $29.80 | $29.35 | Moved to the low end of the guide from the midpoint, consistent with the trimmed margin assumption. |
| FY2026 free cash flow | $6,650M | $6,500M | Moved to the low end of the guide. Management points to the corporate alternative minimum tax ruling supporting the high end; we prefer the low end until the ERP working-capital effect is demonstrably reversed. |
| FY2026 capital expenditures | $2,650M | $2,650M | Unchanged, but now modelled with roughly $500M of customer cash offset per management's disclosure, which is why our operating cash assumption is unchanged despite the lower free cash flow. |
| Share repurchases | ~75% of FCF returned | ~55% of FCF returned | Zero repurchases in Q1 and $1,000M of debt retired. We now assume dividends only, with a token buyback resuming in H2 at the earliest. |
| FY2027 diluted EPS | Implied by 11.3% margin | $31.50 | Now explicit. Assumes 5% sales growth, 11.2% segment margin as ramp dilution unwinds, and a share count roughly flat rather than shrinking 2%. |
| FY2027 free cash flow | $7,300M | $7,000M | Trimmed. The ~$1B pension requirement returns in 2027, capex stays elevated, and the classified program cash burn of $500M–$700M persists through 2027 per management. |
Valuation: We lower our fair value range to $536 to $596 from $596 to $656, on a reduced 18x to 20x multiple applied to a $29.80 guided midpoint. The midpoint of $566 implies roughly 7% upside from the $529.79 close, or roughly 9% including the dividend. The multiple reduction rather than an estimate reduction is the honest expression of what changed: the guide is intact, but the variance around it widened.
Thesis Scorecard Post-Earnings
| Thesis Point | Status | Notes |
|---|---|---|
| Bull #1: Munitions supercycle drives MFC to a larger share of a higher-margin mix | Confirmed | The strongest quarter yet for this pillar. Sales +8.2%, margin dilution of 8bps against a 30bps commitment, ~$7B of PAC-3 awards, and a contract architecture (clawback, escalator, advance payments) that de-risks the ramp. Offset: full rate is 3 to 4 years away, so revenue peaks later than the January framing implied. Tag holds ON TRACK. |
| Bull #2: F-35 definitization removes the cash drag and firm-fixed-price creates margin opportunity | Confirmed | First clear evidence on the margin half: $130M of favourable F-35 profit adjustments, described as accretive to Aeronautics margin, with sustainment volume up ~$325M. Tag improves AT RISK → ON TRACK. |
| Bull #3: Record backlog provides multi-year revenue visibility | Challenged | First decline in our coverage, down $7,195M to $186,427M across all four segments, and MFC flat against $2.2B of in-quarter PAC-3 awards. Still 2.37x guided sales. Tag weakens ON TRACK → AT RISK. |
| Bear #1: Recurring fixed-price development losses are structural, not episodic | Confirmed | $180M of unfavourable adjustments on F-16 and C-130 plus ~$50M at Sikorsky, after two quarters without a reach-forward loss. Notably these were mature production programs, not development work, which broadens rather than narrows the exposure. Tag worsens CONTAINED → EMERGING. |
| Bear #2: Cash conversion is deteriorating and is pre-committed | Neutral | Free cash flow of $(291)M and $6,941M still to earn, against a credible and checkable ERP explanation plus ~$500M of customer capex cash protection. Pension leg remains resolved. Tag holds CONTAINED pending Q2. |
| Bear #3: Earnings growth is buyback-dependent rather than operational | Confirmed | Repurchases went to zero from $750M, with $1,000M of debt retired instead. The 1.8% share count decline is residual from prior buying and decays from here. Tag holds MATERIALIZING. |
| Bear #4: Capital intensity is structurally higher and forward commitments are unreliable | Challenged | Roughly half the $1B capex increase carries customer cash protection, and the framework provisions (clawback, inflation escalator, advance payments, supplier-funded NRE) address the economic objection. Reservation: still frameworks in definitization, and the program's total cost is undisclosed for a second quarter. Tag improves EMERGING → CONTAINED. |
Overall: The thesis moved in both directions and roughly netted out. The two pillars that determine long-run value, the munitions franchise and the F-35 margin structure, both strengthened, and the capital-intensity concern we raised in January turned out to have a contractual answer we did not know about. Against that, the fixed-price execution problem returned in mature production programs where it should not, backlog fell for the first time, and the buyback stopped. Lockheed is a better business than we judged it in January and a less predictable one than we judged it in October.
Action: Maintaining Hold with a fair value range of $536 to $596. In January we said we would upgrade on evidence the capex is converting, specifically MFC margin holding within 30bps of 13.8%, alongside a reaffirmed capital return framework, or on a price below $560. MFC delivered 8bps of dilution and the price broke $560, but the capital return framework moved the other way and the quarter added $180M of program adjustments the trigger did not contemplate. We are one clean quarter from moving. Specifically, we upgrade to Outperform on a Q2 that delivers segment margin above 11%, positive free cash flow confirming the ERP effect reversed, and no new program adjustments. We move to Underperform if Q2 brings further F-16, C-130 or Sikorsky adjustments, or if free cash flow through H1 leaves more than $7B required in the second half.